Company
Orikine Bio
Precision-engineered, bi-specific cytokines to treat autoimmune and inflammatory diseases
Also known as ORIKINE BIO, SL
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
- Headquarters
- Barcelona, Spain
- Founded
- 2022
- Legal name
- ORIKINE BIO, SL
Claim, correct or request removal
Record updated 28 September 2026
About
Highly versatile protein-design platform to develop optimal cytokine therapeutics that can deliver the desired signalling to the desired cell and/or tissue to achieve a maximum in efficacy and safety.
Funding snapshot
- Latest round
- Grant2024-12-17
Funding rounds
- Grant
- 2024-12-17
- Seed
- Recorded
Loading relationship preview